Interview
with Neil Love, MD from Breast Cancer Update for Medical Oncologists,
Program 2 2000
Play
Audio Below:
When
you have a patient with a 50% or 80% chance of recurring and dying
of their disease, you have a tendency to, first of all, want to
make sure you’re giving them everything. And secondly, you
know, we have a tradition that goes back to Hippocrates. Hippocrates
said that, "dire diseases require dire remedies." And
I think sometimes we think that things such as tamoxifen can’t
possibly be so effective against cancer because, after all, they
don’t cause many side effects. It just is not part of our culture.
As
the years have gone by I’ve given more and more credit to the
effects of chemotherapy on ovarian function and less and less credit
to its direct effect. The other thing that’s kind of interesting
is that you usually see the effects of chemotherapy, the relative
effects of ovarian ablation, and tamoxifen versus chemotherapy,
the chemotherapy having a greater impact on disease-free survival
and overall survival. In other words, the added benefit is greater
in prolonging time of occurrence than it is in actually prolonging
time to death.
Anxiety
in cancer patients [Review].
Stark, D. P. H. and House, A. (Reprint available from: Stark DPH
St James Univ Hosp, Imperial Canc Res Fund, Dept Med Oncol Beckett
St Leeds LS9 7TF W Yorkshire England). British Journal of Cancer.
83(10):1261-1267, 2000 Nov. In progress
Utilization
of professional supportive care services by women with breast cancer.
Gray,
R. E.; Goel, V.; Fitch, M. I.; Franssen, E.; Chart, P.; Greenberg,
M.; Bakker, D.; Labrecque, M.; Hollowaty, E.; Godel, R., and Hampson,
A. W. (Reprint available from: Gray RE Univ Toronto, Toronto Sunnybrook
Reg Canc Ctr, Psychosocial & Behav Res Unit 2075 Bayview Ave
Toronto ON M4N 3M5 Canada). Breast Cancer Research & Treatment.
64(3):253-258, 2000 Dec
